Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Julio Manzitti"'
Autor:
Matias Ramirez Gismondi, Julio Manzitti, Daniel A. Benisek, Romina Quercia, Marcelo A. Tinelli, Andres M. Rousselot Ascarza, María Lourdes Scorsetti, Daniel H. Scorsetti, Maria Penna, Mateo A. Carpio Total, Amalia A. Ascarza, Francisco J. Fernández, Diego Gomez Rancaño, Eduardo Spitzer, Carola Lombas, Matías Deprati
Publikováno v:
Experimental and Therapeutic Medicine. 20:1-1
The present study was an open-label, prospective, uncontrolled and multicenter clinical trial to investigate the safety and effectiveness of bevacizumab (Lumiere®) administered by the intravitreal route for the treatment of neovascular age-related m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d39fc362f4db128e081a70f2295b220
https://doi.org/10.3892/etm.2020.9291
https://doi.org/10.3892/etm.2020.9291
Autor:
Alejandro Dinerstein, Luxme Hariharan, Ernesto Alda, Andrea Zin, Alicia M Benítez, Clare Gilbert, Julio Manzitti, Marina Brussa, Patricia Visintin, Celia Lomuto, Adriana Cattaino, Norma Erpen, Liliana Bouzas, Lidia Galina, Ana Quiroga, Frances K. Barg, Joan McLeod-Omawale, Cynthia Magluta, Juan Carlos Silva, Teresa Sepúlveda, Adriana Fandiño, Graham E. Quinn, Silvia Marinaro, Zulma Ortiz
Retinopathy of prematurity (ROP) is a largely avoidable cause of blindness in children worldwide, requiring high-quality neonatal care, early detection and treatment. In middle-income countries throughout Latin America, Eastern Europe and South Asia,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::236c0a7c0a393eac1876a4bce3904bd1
https://researchonline.lshtm.ac.uk/id/eprint/4647446/1/Reducing-Blindness-from-Retinopathy-of-Prematurity-ROP-in-Argentina.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4647446/1/Reducing-Blindness-from-Retinopathy-of-Prematurity-ROP-in-Argentina.pdf
Autor:
Adriana Fandiño, Elsa C. Raslawski, Enrique Schvartzman, Guillermo L. Chantada, Paula Schaiquevich, Julio Manzitti
Publikováno v:
Pediatric Blood & Cancer. 61:821-826
Background Few studies were reported from developing countries regarding patient outcome and ocular survival in children with bilateral retinoblastoma treated with chemoreduction compared to external beam radiotherapy (EBRT). Procedure We undertook a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7960fdac1fbb52d4a1aa9f0e539a793
https://doi.org/10.1002/pbc.24857
https://doi.org/10.1002/pbc.24857
Autor:
Julio Manzitti, Laura Peralta, Mariana Sgroi, Eduardo Lagomarsino, Claudia Sampor, Guillermo L. Chantada, Francisco Villasante, Santiago Funes, Pablo Neira, Paula Schaiquevich, Adriana Fandiño, Alejandro Ceciliano
Publikováno v:
Pediatric Blood & Cancer. 65:e27086
Background: The feasibility and results of intraarterial chemotherapy, also termed ophthalmic artery chemosurgery (OAC), for retinoblastoma in less developed countries have seldom been reported. Procedure: A retrospective evaluation of a program of O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c11a98d1cb795b0e49232cdd97181e0c
https://doi.org/10.1002/pbc.27086
https://doi.org/10.1002/pbc.27086
Autor:
María T. G. de Dávila, Julio Manzitti, Adriana Fandiño, Elsa C. Raslawski, Marcelo Scopinaro, Sandra J. Casak, Enrique Schvartzman, Guillermo L. Chantada
Publikováno v:
Pediatric Blood & Cancer. 44:455-460
Background Chemoreduction is used for the treatment of retinoblastoma in industrialized nations; however, there are fewer data from developing countries. Before the implementation of this program, radiotherapy was used in almost all preserved eyes. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6a9569a96ba8e30ca2a65e7408b16e5
https://doi.org/10.1002/pbc.20259
https://doi.org/10.1002/pbc.20259
Autor:
Sandra J. Casak, Adriana Fandiño, Guillermo L. Chantada, Enrique Schvartzman, Julio Manzitti, Gabriel Mato
Publikováno v:
Ophthalmic Genetics. 25:37-43
To report our experience with topotecan in children with relapsed/refractory metastatic and intraocular retinoblastoma.Topotecan was administered intravenously as a 30-min infusion at a dose of 2 mg/m2/d for five consecutive days and repeated after t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d445efcfb0b558bee37add5a1f1e081
https://doi.org/10.1076/opge.25.1.37.28996
https://doi.org/10.1076/opge.25.1.37.28996
Autor:
Guillermo Chantada, Enrique Schvartzman, Julio Manzitti, Sandra Casak, Elsa Raslawski, Adriana Fandiño, María T. G. Dávila M.D.
Publikováno v:
Cancer. 100:834-842
BACKGROUND The objectives of this prospective study were to avoid adjuvant treatment for patients with intraocular disease and patients with postlaminar optic nerve invasion (PL-ONI) without full choroidal or scleral invasion. Adjuvant chemotherapy (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49c29fead19c18a2f159d902d1219f45
https://doi.org/10.1002/cncr.11952
https://doi.org/10.1002/cncr.11952
Publikováno v:
Archives of Disease in Childhood. 80:171-174
Objectives—To assess the diagnostic process of retinoblastoma in a developing country. Study design—Prospective survey of 95 consecutive parents of patients with retinoblastoma. Results—Fifty six parents consulted initially with a paediatrician
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dfa92a1df5c1d92a6039e880bc4f382
https://doi.org/10.1136/adc.80.2.171
https://doi.org/10.1136/adc.80.2.171
Autor:
Adriana Fandiño, Sandra Casak, Elsa C. Raslawski, María T. G. de Dávila, Enrique Schvartzman, Julio Manzitti, Guillermo L. Chantada
Publikováno v:
Ophthalmic Genetics. 20:133-140
To define a subgroup of patients with retino-blastoma and low risk of extraocular relapse through histopathological and clinical variables.Inclusion criteria consisted of stage I (intraocular disease), stage IIb1 (without concomitant choroid and/or s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::143227c1954901c1cf96fb677637c82d
https://doi.org/10.1076/opge.20.3.133.2277
https://doi.org/10.1076/opge.20.3.133.2277
Autor:
Daniel Borelina, Sergio E. Baranzini, Cristina Barreiro, Alejandra Arbetman, Mirta Abdala, Adriana Fandiño, Irene Szijan, Jorge Herrera, Julio Manzitti, Diana Lidia Parma, Florencia Giliberto
Publikováno v:
Journal of American Association for Pediatric Ophthalmology and Strabismus. 2:102-107
Purpose: The purpose of this study is to determine the clinical, chromosomal, and molecular characteristics of Argentine patients with unilateral and bilateral retinoblastoma. Study Design: Eighty-six patients belonging to 82 families were studied; 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd5efd94c972e4ab6466028ea01328c3
https://doi.org/10.1016/s1091-8531(98)90072-6
https://doi.org/10.1016/s1091-8531(98)90072-6